BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Eagle Pharmaceuticals Reports Third Quarter 2017 Results

  Total revenue for the third quarter of 2017 grew 67% to $63.0 million compared to $37.8 million in the third quarter of 2016.

  November 8, 2017

   · 

  19 min read
• Standigm, an AI Based Drug Discovery Company, Launched AI Drug Discovery Services Publicly at Bio-Europe 2017 in Berlin, Germany

  Bio-Europe is the Europe’s largest partnering conference for the biotechnology industry.

  November 8, 2017

   · 

  2 min read
• Business

  Oncolytics Biotech Announces 2017 Third Quarter Results

  Oncolytics Biotech today announced its financial results and operational highlights for the quarter ended September 30, 2017.

  November 8, 2017

   · 

  24 min read
• Pharm Country

  New Clinical Data and Insurance Coverage Support Mederi’s Stretta Therapy for GERD

  An interim analysis of a randomized controlled trial was recently published in the October 2017 issue of the Indian Journal of Gastroenterology.

  November 8, 2017

   · 

  2 min read
• Business

  RXi Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

  A live audio webcast will begin today at 4:30 p.m. ET. The webcast link is available under the “Investors - Events and Presentations” section of the Company’s website, www.rxipharma.com.

  November 8, 2017

   · 

  16 min read
• Business

  Sage Therapeutics Appoints Asha Nayak, M.D., Ph.D., to Board of Directors

  Dr. Nayak currently serves as chief medical officer at Intel Corporation where she guides its healthcare investment strategy and provides clinical and business leadership to Intel’s broad spectrum of healthcare programs.

  November 8, 2017

   · 

  2 min read
• Positive Preclinical Data for ALKS 4230 Presented at Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

  A poster on the preclinical data, titled, “A Novel, Individualized Xenograft Model of Cancer Immunotherapy and Tumor Growth Inhibition by ALKS 4230,” will be presented by Dr. Brian Gastman of the Cleveland Clinic at SITC in National Harbor, Md. on Friday, Nov. 10, 2017 (Poster #P351).

  November 8, 2017

   · 

  5 min read
• Business

  Visioneering Technologies Promotes Jeff Babbe to District Manager for the Midwest Region

  Based in Skokie, IL, Babbe will be responsible for oversight of sales representatives in the expanding Midwest Region, as well as executing the sales strategy for the NaturalVue brand portfolio of products.

  November 8, 2017

   · 

  2 min read
• Business

  Seres Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Operational Progress

  Seres reported a net loss of $6.9 million for the third quarter of 2017, as compared to a net loss of $18.7 million for the same period in 2016.

  November 8, 2017

   · 

  13 min read
• Novocure Announces 13 Preclinical Presentations Highlighting Data on Tumor Treating Fields’ Mechanism of Action at 22nd Annual Meeting of the Society for Neuro-Oncology

  In total, 60 abstracts on Tumor Treating Fields, including two oral presentations, will be presented.

  November 8, 2017

   · 

  6 min read